학술논문
Second-line treatment of HER2-positive metastatic breast cancer: Trastuzumab beyond progression or lapatinib? A population based cohort study
Document Type
Article
Source
In: PLoS ONE . (PLoS ONE, 16 September 2015, 10(9))
Subject
Language
English
ISSN
19326203